Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' CSL Biotherapies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CSL Biotherapies, Inc. since January 2007.
– Provides intelligence on CSL Biotherapies, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by CSL Biotherapies, Inc. and its subsidiaries since 2007. – Information about key financial and legal advisors for CSL Biotherapies, Inc.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes CSL Biotherapies, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by CSL Biotherapies, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about CSL Biotherapies, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The global bio-based platform chemicals market is expected to exhibit strong growth during 2021-2026. Bio-based platform chemicals refer to the group of chemical compounds manufactured by breaking down and processing biological materials. Some of the commonly used bio-based platform chemicals include bio-glycerol, glutamic...
120 pages •
By Infiniti Research Limited
• Nov 2021
Global Papaya Market 2022-2026 The analyst has been monitoring the papaya market and it is poised to grow by 2511.93 thousand tons during 2022-2026, progressing at a CAGR of 3.29% during the forecast period. Our report on the papaya market provides a holistic analysis, market size and forecast, trends, growth drivers, and...
The global automated liquid handlers market was valued at USD 685.96 million in 2020, and it is expected to reach USD 939.92 million by 2026, with an estimated CAGR of 5.39%, from 2021 to 2026. Key Highlights - The flexibility and adaptability of automation systems made automated liquid handlers’ equipment widely...
KEY FINDINGS The global aseptic pharma processing & packaging equipment market is set to progress with a CAGR of 7.12% during the forecasted years of 2021 to 2028. The market growth of the country is associated with key drivers such as the increasing demand for generics and biopharmaceuticals markets, the rising adoption...
The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report. This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to grow from $0.96 billion in 2020 to $1.1 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is...
Pharmaceutical Membrane Filtration market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharmaceutical Membrane Filtration Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharmaceutical Membrane Filtration...
Pharma-grade Synthetic Camphor market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharma-grade Synthetic Camphor Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharma-grade Synthetic Camphor types,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.